InnoBio Fund
Signal active
Investment Firm
Overview
InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in the healthcare market.
Highlights
Founded
2009
Industry
Employees
0
Investment
14
Lead Investment
3
Exits
8
Stages
Late Stage Venture, Early Stage Venture, Seed
Investor Type
Government Office, Venture Capital
Location
Europe
Contact Information
Social
N/A
Profile Resume
InnoBio Fund, established in 2009 and headquartered in Europe., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Biotechnology, Medical Device, Therapeutics, Financial Services, Venture Capital, Finance, Banking, Pharmaceutical, Health Diagnostics, Retail. The organization boasts a portfolio of 14 investments, with an average round size of $18.1M and 8 successful exits. Their recent investments include Genticel, Idinvest Partners, Andera Partners, Amundi Private Equity Funds, Poxel. The highest investment round they participated in was $16.5B. Among their most notable exits are Genticel and Idinvest Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
InnoBio Fund has made 14 investments. Their most recent investment was on Mar 14, 2023, when AlgoTherapeutix raised $21.5M.
InnoBio Fund has made 1 diversity investments. Their most recent diversity investment was on Aug 09, 2018, when Millendo Therapeutics raised $30.0M.
investments
14
Diversity investments
1
Lead investments
3
Number of exits
8
Investments
14
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 20, 2017 | Advicenne | Biotechnology | 17.2M |
| Aug 09, 2018 | Millendo Therapeutics | Biotechnology | 30.0M |
| Jul 07, 2020 | Diotheris | Biotechnology | null |
| Mar 14, 2023 | AlgoTherapeutix | Information Technology | 21.5M |
Millendo TherapeuticsExits
8
Funding Timeline
Funding rounds
14
Investors
0
Funds
0
Funding Rounds
14
InnoBio Fund has raised 14 rounds. Their latest funding was raised on Mar 14, 2023 from a Series B - AlgoTherapeutix round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 20, 2017 | Venture Round - Advicenne | - | 17.2M | - |
| Aug 09, 2018 | Venture Round - Millendo Therapeutics | - | 30.0M | - |
| Jul 07, 2020 | Seed Round - Diotheris | - | 0 | - |
| Mar 14, 2023 | Series B - AlgoTherapeutix | - | 21.5M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.